Vacinação, segurança de imunobiológicos e direitos do cidadão

Silva, Luiz Jacintho da

doi:10.1590/s0034-89101996000400001

Cited by 7 publications

(5 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As reações locais (vermelhidão, calor e edema, acompanhadas ou não de dor) ocorrem entre 30 a 50% das crianças, podem ou não comprometer transitoriamente a movimentação do membro e não impedem o prosseguimento da vacinação, cabendo destacar que a sua freqüência aumenta com a aplicação de doses subseqüentes (11)(12)(13) . Porém, as reações parecem ser mais influenciadas pela idade que pela dose da vacina (14) .…”

Section: Discussionunclassified

Análise dos eventos adversos pós-vacinais ocorridos em Teresina

Araújo¹,

Carvalho²,

Vieira³

2007

Rev. Bras. Enferm.

View full text Add to dashboard Cite

This study focuses the profile of the adverse events after-vaccine occurrences in Teresina in 2006. The data had been collected by means of the form application with 73 participants in 18 Basic Units of Health. The results show that the vaccines that had more produced events adverse had been tetravalente, BCG and DPT The events most frequent had been: fever, hiporresponsivo hipotonic episode, moderate irritability and local manifestations. Amongst the behaviors adopted for the health professionals, 80% had been approximately adjusted. The year minors had been accomitted by the events. All the events had evolved for the cure. It was concluded that the action of vaccination still continues requiring constant qualification of the professionals of the area. It is suggested to deepen the knowledge with relation to the handling, diagnosis, inquiry and treatment.

show abstract

Section: Discussionunclassified

Análise dos eventos adversos pós-vacinais ocorridos em Teresina

Araújo¹,

Carvalho²,

Vieira³

2007

Rev. Bras. Enferm.

View full text Add to dashboard Cite

show abstract

“…52,99 The latter attribute is of particular importance in situations that involve serious risk to the health of the popuation, such as the outbreak of Guillan-Barré syndrome taken place in the United States in 1976, associated with mass vaccination against the H1N1 infl uenza virus, 91 or the identifi cation of overly reactogenic vaccine batches, which should be recalled immediately. 92 The minimal required information for the proper functioning of a SAEFI system are: type of vaccine, date of administration and onset of clinical manifestations; type of health service and characteristics of the health care unit in which the vaccine was administered, characteristics of the vaccinee, and clinical manifestations. In case of hospitalization, it is also necessary to obtain information on duration, conditions at discharge, and conduct regarding the continuity of the vaccination schedule.Information on co-morbidities, personal and family morbidity history, prior history of AEFIs, and type of adverse reaction.…”

Section: Goals and Attributes Of Saefi Systemsmentioning

confidence: 99%

“…In spite of its being a more recent initiative, and of the limitations inherent to passive surveillance, 52,105 the Brazilian SAEFI system has been successful in identifying more reactogenic vaccines and/or batches, 34,92 as well as less known or previously unrecognized AEFIs, as was the case with the yellow fever vaccine. 102 One peculiarity of the Brazilian experience is that the SEAFI system was implemented prior to a phrarmacosurveillance system rather than as one of its branches.…”

Section: Different Saefi Experiencesmentioning

confidence: 99%

Vigilância de eventos adversos pós-vacinação e segurança de programas de imunização

et al. 2011

View full text Add to dashboard Cite

The aim of the review was to analyze conceptual and operational aspects of systems for surveillance of adverse events following immunization. Articles available in electronic format were included, published between 1985 and 2009, selected from the PubMed/Medline databases using the key words "adverse events following vaccine surveillance", "post-marketing surveillance", "safety vaccine" and "Phase IV clinical trials".Articles focusing on specifi c adverse events were excluded.The major aspects underlying the Public Health importance of adverse events following vaccination, the instruments aimed at ensuring vaccine safety, and the purpose, attributes, types, data interpretation issues, limitations, and further challenges in adverse events following immunization were describe, as well as strategies to improve sensitivity.The review was concluded by discussing the challenges to be faced in coming years with respect to ensuring the safety and reliability of vaccination programs.

show abstract

“…Yet in approximately 50% of the AEFI-T, the time for register in the AEFI database was no less than 60 days. Despite this limitation the PSAEFI has successfully identified highly reactogenic vaccine batches 23,24 . In addition, it has good acceptability 6 , though it may be overestimated given the requirements for to register the event in the AEFI electronic database.…”

Section: Discussionmentioning

confidence: 99%